Company profile
Azitra, Inc.
AMEX:AZTRBiotechnology: Pharmaceutical Preparations
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06830863 | phase1_2 | recruiting | 2025-08-25 | 2027-01-15 | Azitra Inc. | A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity |
| NCT06137157 | phase1 | completed | 2024-06-16 | 2026-07-07 | Azitra Inc. | Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome |
| NCT04731259 | phase1_2 | withdrawn | 2024-01-01 | 2026-01-01 | Azitra Inc. | Study to Evaluate the Safety of ATR-04 |
FDA applications (0)
No records yet.